$3.82
-0.02-0.52%
In chiusura: Nov 18, 4:00 PM EST
$3.90
0.082.09%
Post-mercato: 7:43 PM EST
Prime Medicine (PRME) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q3 | Nov 12, 2026 | $-0.22 | $-0.24 | 8.33 % |
| Q2 | Aug 6, 2026 | $-0.24 | $-0.25 | 4.00 % |
| Q1 | May 7, 2026 | $-0.28 | $-0.25 | -12.0 % |
| Q4 | Mar 3, 2026 | $-0.24 | $-0.25 | 4.00 % |
Quarterly Revenue (Billions)
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q3 | Nov 12, 2026 | $4.21M | $2.00M | 110.9 % |
| Q2 | Aug 6, 2026 | $1.15M | $1.76M | -34.6 % |
| Q1 | May 7, 2026 | $856.00K | $1.02M | -16.0 % |
| Q3 | Nov 7, 2025 | $1.23M | $4.25M | -71.2 % |
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.24 | $-0.25 | $-0.25 | $-0.25 |
| Actual | $-0.22 | $-0.24 | $-0.28 | $-0.24 |
| Surprise | +8.33% | +4.00% | -12.0% | +4.00% |
| Revenue | ||||
| Estimate | $2.0M | $1.8M | $1.0M | $2.2M |
| Actual | $4.2M | $1.2M | $856000 | $838000 |
| Surprise | +110.9% | -34.6% | -16.0% | — |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.22 | $-0.22 | $-0.22 | $-0.21 |
| Revenue | ||||
| Consensus | $7.3M | $1.6M | — | — |
